Medication overuse headache: Predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study

Cephalalgia

Volumn 28, Issue 11, 2008, Pages 1196-1200

  Rossi, P ^a,b   Faroni, J V ^a   Nappi, G ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b Headache Clinic INI Grottaferrata   (Italy)

Author keywords

Management; Medication overuse headache; Migraine; Relapse

Indexed keywords

ANALGESIC AGENT; ERGOT ALKALOID; TRIPTAN DERIVATIVE;

ADULT; ANALGESIC AGENT ABUSE; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG INDUCED HEADACHE; DRUG USE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MIGRAINE; MORBIDITY; PROGNOSIS; RECURRENCE RISK; RELAPSE;

ADULT; ANALGESICS; DIRECTIVE COUNSELING; FEMALE; FOLLOW-UP STUDIES; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 53549085952     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01659.x     Document Type: Article

References (15)

1. Diener HC, Silberstein SD. Medication overuse headache. In : Olesen J, Goadsby PJ, Ramadan NR et al., eds. The headaches, 3rd edn. Philadelphia, PA : Lippincott Williams and Wilkins 2006 : 976 7
2. Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 2003 60 : 1682 3.
3. Katsarava Z, Mussig M, Dzagniza A, Frietsche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005 25 : 12 15.
4. Zidvert-Trajkovic J, Pekmezovic T, Jovanovic Z, Pavlovic A, Mijajlovic M, Radojicic A, Sternic N. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia 2007 27 : 1219 25.
5. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999 19 : 44 9.
6. Tribl GG, Schnider P, Wober C, Aull S, Auterith A, Zeiler K, Wessely P. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headaches? Cephalalgia 2001 21 : 691 6.
7. Saper JR, Hamel RL, Lake AE III. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 2005 25 : 545 6.
8. Lake AE III. Medication overuse headache: biobehavioural issues and solutions. Headache 2006 46 (Suppl. 3 S88 97.
9. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006 26 : 1097 105.
10. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M et al. The International Classification of Headache Disorders, 2nd edition (ICHD-II)-revision oc criteria for 8.2 Medication Overuse Headache. Cephalalgia 2005 25 : 460 5.
11. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 26 : 742 6.
12. Katzarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol 2007 20 : 326 30.
13. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004 62 : 788 90.
14. Scher AISW, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003 106 : 81 9.
15. Ferrari A, Leone S, Vergoni AV, Bertolini A, Sances G, Coccia CPR et al. Similarities and differences between chronic migraine and episodic migraine. Headache 2007 47 : 65 72.